Published in Arch Ophthalmol on November 01, 1999
Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes (WESCID) | NCT00005539
Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care (2008) 2.80
Vision impairment predicts 5 year mortality. Br J Ophthalmol (2001) 1.98
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol (2004) 1.59
The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2006) 1.51
The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology (2009) 1.47
The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol (2002) 1.33
Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett (2008) 1.25
Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care (2011) 1.23
Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. Arch Ophthalmol (2012) 1.21
Clinically significant macular edema and survival in type 1 and type 2 diabetes. Am J Ophthalmol (2008) 1.06
Retinopathy as a predictor of other diabetic complications. Int Ophthalmol (2001) 0.98
Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome. Am J Ophthalmol (2010) 0.97
Arterial stiffness is associated with diabetic retinopathy in Korean type 2 diabetic patients. J Prev Med Public Health (2011) 0.97
Relationship of measures of frailty to visual function: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2003) 0.95
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. J Am Heart Assoc (2012) 0.92
Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care (2012) 0.91
Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia. BMJ Open Diabetes Res Care (2014) 0.84
Heart in diabetes: a microvascular disease. Diabetes Care (2011) 0.83
Hospitalized cardiovascular events in patients with diabetic macular edema. BMC Ophthalmol (2012) 0.81
Prevalence of systemic co-morbidities in patients with various grades of diabetic retinopathy. Indian J Med Res (2014) 0.79
Optimal treatment of diabetic retinopathy. Ther Adv Endocrinol Metab (2013) 0.78
Impact of socioeconomic deprivation on the development of diabetic retinopathy: a population-based, cross-sectional and longitudinal study over 12 years. BMJ Open (2015) 0.78
Mortality in Older Persons with Retinopathy and Concomitant Health Conditions: The Age, Gene/Environment Susceptibility-Reykjavik Study. Ophthalmology (2016) 0.78
Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2013) 0.77
Non-standard vision measures predict mortality in elders: the Smith-Kettlewell Institute (SKI) study. Ophthalmic Epidemiol (2010) 0.76
Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study. Medicine (Baltimore) (2015) 0.75
Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure: Evidence from epidemiological observational studies. Medicine (Baltimore) (2017) 0.75
Effect of physical activity on mortality risk among Americans with retinopathy. Health Promot Perspect (2016) 0.75
Immediate effect of bitter gourd, ash gourd, Knol-khol juices on blood sugar levels of patients with type 2 diabetes mellitus: A pilot study. J Tradit Complement Med (2017) 0.75
Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 10.88
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
The Wisconsin age-related maculopathy grading system. Ophthalmology (1991) 7.62
The Beaver Dam Eye Study: visual acuity. Ophthalmology (1991) 6.87
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 6.47
Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol (1998) 6.04
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46
Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA (1988) 4.31
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology (1998) 4.21
The 14-year incidence of visual loss in a diabetic population. Ophthalmology (1998) 4.08
Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol (2000) 3.94
Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA (1998) 3.86
The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes (1984) 3.66
Visual impairment in diabetes. Ophthalmology (1984) 3.64
The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1993) 3.58
The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol (1994) 3.24
Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology (1985) 3.20
The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2000) 3.17
Endocytic vesicles move at the tips of actin tails in cultured mast cells. Nat Cell Biol (1999) 3.17
An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05
The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci (1995) 2.99
Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology (1996) 2.98
Ten-year incidence of visual loss in a diabetic population. Ophthalmology (1994) 2.91
Cause-specific mortality in a population-based study of diabetes. Am J Public Health (1991) 2.89
Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. J Am Geriatr Soc (1998) 2.88
Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study. Ophthalmology (2001) 2.71
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology (1995) 2.70
The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology (1992) 2.70
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1989) 2.59
Reflections on sex-related risk of eye disease. Arch Ophthalmol (2001) 2.54
Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol (2001) 2.51
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology (1989) 2.51
Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology (1998) 2.50
Association of NIDDM and hearing loss. Diabetes Care (1998) 2.45
Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol (1994) 2.39
The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol (1993) 2.37
Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1994) 2.36
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA (1999) 2.35
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology (1991) 2.34
The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care (1999) 2.33
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol (1989) 2.31
Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology (1985) 2.26
The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol (1991) 2.14
Dietary fat and age-related maculopathy. Arch Ophthalmol (1995) 2.11
Diversity in the lipocortin/calpactin family. Cell (1988) 2.11
Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology (1999) 2.10
A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr (1993) 2.06
Diabetic retinopathy. Assessment of severity and progression. Ophthalmology (1984) 2.05
The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol (1998) 1.93
Epidemiology of proliferative diabetic retinopathy. Diabetes Care (1992) 1.91
Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol (1994) 1.91
Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology (1995) 1.86
The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med (2000) 1.86
Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol (1993) 1.81
Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol (2000) 1.79
Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med (1994) 1.78
Accuracy of self-reported hearing loss. Audiology (1998) 1.77
Diet and nuclear lens opacities. Am J Epidemiol (1995) 1.73
Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol (1999) 1.73
Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative. Neurology (2012) 1.68
Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol (1998) 1.65
How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol (2001) 1.65